Physician profile
Jesse Richman
NPI 1346402872
$30,416.81
in general payments reported to CMS, 2019-2025
16 companies · $7,587 in 2025
The $7,587 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $762 · 2021: $2,059 · 2022: $4,136 · 2023: $7,924 · 2024: $7,772 · 2025: $7,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,723 · Food and Beverage: $3,213 · Honoraria: $38.86 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,290.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,723.00 |
| Food and Beverage | $3,212.75 |
| Honoraria | $38.86 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $12,281.79 | 2019-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Abbvie INC. | $7,009.09 | 2022-2025 | |
| Rxsight INC | $6,403.80 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Ivantis, INC | $2,646.50 | 2020-2021 | |
| Alcon Research LLC | $980.00 | 2023 | |
| Glaukos Corporation | $326.76 | 2022-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $284.71 | 2020-2025 | Tecnis Iol, Tecnis Simplicity |
| Sight Sciences, INC. | $268.32 | 2019-2025 | Omni Surgical System |
| Allergan, INC. | $58.24 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $45.30 | 2022-2023 | Miebo |
| New World Medical,INC. | $29.02 | 2025 | Streamline, Clearpath, Via360 |
| Harrow Eye, LLC | $20.51 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Ani Pharmaceuticals, INC. | $16.98 | 2025 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $15.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $13.55 | 2024 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Richman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.